Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

High-profile coronavirus retractions raise concerns about data oversight

Retracted studies had relied on health-record analyses from a company that declined to share its raw data for an audit.
  1. Heidi Ledford
    View author publications

    You can also search for this author in PubMed  Google Scholar

  2. Richard Van Noorden
    View author publications

    You can also search for this author in PubMed  Google Scholar

Two weeks after a high-profile paper in The Lancet1 reported that the antimalarial drug hydroxychloroquine might be dangerous to patients with COVID-19, three of its four authors have retracted the work because they were unable to independently verify their data set, a large proprietary collection of electronic health records analysed by Surgisphere, a US company.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 582, 160 (2020)

doi: https://doi.org/10.1038/d41586-020-01695-w

Additional reporting by Smriti Mallapaty and David Cyranoski

References

  1. Mehra, M. R., Desai, S. S., Ruschitzka, F. & Patel, A. N. Lancet https://doi.org/10.1016/S0140-6736(20)31180-6 (2020).

    Article  Google Scholar 

  2. Mehra, M. R., Desai, S. S., Kuy S., Henry, T. D. & Patel, A. N. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2007621 (2020).

    Article  Google Scholar 

  3. Boulware, D. R. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2016638 (2020).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links